Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_1
1
11%
Ph phase_2
1
11%
Ph phase_4
1
11%
Ph early_phase_1
1
11%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

terminated111%
unknown222%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
9